Subcutaneous DMPA Key Facts

 Subcutaneous DMPA Key Facts Answering questions and dispelling common myths about a new type of injectable contraception.       Published: 2017 Source: Reproductive Health Supplies Coalition Back to...

DMPA and HIV: What Advocates Need to Know

DMPA and HIV: What Advocates Need to Know This tool summarizes important takeaways for advocates from new guidance released by the WHO in 2017 on hormonal contraception, including DMPA injectables, and HIV for women at high risk of HIV. Incorporate the information in...

Thinking about Using Depo? Things to Consider

Thinking about Using Depo? Things to Consider This pamphlet was designed for women considering using Depo-Provera as a contraceptive method. It provides important information about the relationship between Depo-Provera and HIV, about taking Depo when using ARVs, and...

Webinar: WHO Guidance on Hormonal Contraceptive Eligibility for Women Living at High Risk of HIV Acquisition

Webinar: WHO Guidance on Hormonal Contraceptive Eligibility for Women Living at High Risk of HIV Acquisition Dr. James Kiarie, coordinator of the Human Reproduction Team at WHO. Dr. Kiarie presented the released guidance on hormonal contraceptive eligibility for women...

Hormonal Contraceptive Eligibility for Women at High Risk of HIV Guidance Statement

Hormonal Contraceptive Eligibility for Women at High Risk of HIV The World Health Organization (WHO) convened a technical consultation during 1–2 December 2016 to review new evidence on the risk of HIV acquisition with the use of hormonal contraception. The issue was...